Circulating tumor cells in precision medicine: challenges and opportunities

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Tumor landscapes are dynamic, necessitating continuous patient monitoring for effective cancer care.
• Circulating tumor cells (CTCs) in liquid biopsies provide critical tumor DNA, RNA, and protein data.
• CTCs are emerging as valuable biomarkers for personalized cancer treatment.

Purpose of the Study:

• To summarize recent advances in CTC enumeration, characterization, and expansion.
• To discuss the limitations of current CTC analysis techniques.
• To identify future research directions for clinical CTC applications.

Main Methods:

• Review of recent studies on CTC enumeration and characterization.
• Analysis of CTC expansion techniques for personalized medicine.
• Evaluation of CTCs as biomarkers in clinical settings.

Main Results:

• Advances in CTC analysis are enhancing personalized cancer treatment strategies.
• CTC enumeration and characterization are increasingly validated for clinical use.
• The potential of CTCs as a standard biomarker in cancer care is being realized.

Conclusions:

• CTCs are a powerful tool for monitoring cancer and guiding treatment.
• Further research is needed to overcome limitations and fully integrate CTC analysis into clinics.
• Optimizing CTC analysis will improve patient outcomes through personalized oncology.